Litcius/Paper detail

Inhibition of macrophage inflammasome assembly and pyroptosis with GC-1 ameliorates acute lung injury

Bin Li, Jingyi Liu, Wanyu He, Yanlin Zhou, Man Zhao, Cong Xia, Xiaoyue Pan, Zhihua Ji, Ruoyu Duan, Hui Lian, Kai Xu, Guoying Yu, Lan Wang

2025Theranostics23 citationsDOIOpen Access PDF

Abstract

This study presents a novel mechanism for treating ALI in which GC-1 inhibits macrophage ROS-mediated inflammasome assembly and pyroptosis through Nrf2-p53-ASC pathway. These findings highlight the promising potential of the use of GC-1 as an anti-inflammatory and antioxidant drug in the treatment of ALI/ARDS.

Topics & Concepts

PyroptosisInflammasomeMacrophageCaspase 1Alveolar macrophageLungChemistryInflammationMedicineImmunologyBiochemistryIn vitroInternal medicineInflammasome and immune disordersPulmonary Hypertension Research and Treatments
Inhibition of macrophage inflammasome assembly and pyroptosis with GC-1 ameliorates acute lung injury | Litcius